| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Medical Officer | Senior VP - CMO
1 company
Sheridan William P is a Chief Medical Officer at BCRX. Recent filings cover 0 purchases and 9 sales. Those positions are worth an estimated $670K at current prices.
Our model assigns Sheridan William P a middling insider score of 67/100, based on 3 past trades. Over a 12-month horizon, 100.0% of those trades were profitable, with an average 12-month return of +40.9%.
Sheridan William P's largest disclosed position is in BCRX as Chief Medical Officer, worth about $670K. The recent filings there lean toward selling, a net 555,372 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar 10, 2022 | BCRX Biocryst Pharmaceuticals Inc | Chief Medical Officer | Sale+OE | 161,139 | $16.88 | $2,719,492.93 | -80.9% | -35.4% | -50.8% | |
| May 28, 2021 | BCRX Biocryst Pharmaceuticals Inc | Chief Medical Officer | Sale+OE | 163,573 | $15.01 | $2,455,431.28 | -91.9% | -2.7% | -38.1% | |
| Feb 22, 2021 | BCRX Biocryst Pharmaceuticals Inc | Senior VP - CMO | Sale+OE | 41,250 | $11.57 | $477,262.50 | -78.2% | - | - | |
| Dec 18, 2018 | BCRX Biocryst Pharmaceuticals Inc | Senior VP - CMO | Sell | 20,488 | $7.58 | $155,299.04 | -88.3% | - | - | |
| Aug 9, 2018 | BCRX Biocryst Pharmaceuticals Inc | Senior VP - CMO | Sale+OE | 62,500 | $7.03 | $439,375.00 | -72.9% | - | - | |
| Jun 1, 2018 | BCRX Biocryst Pharmaceuticals Inc | Senior VP - CMO | Sale+OE | 42,112 | $6.30 | $265,305.60 | -66.7% | - | - | |
| Nov 13, 2017 | BCRX Biocryst Pharmaceuticals Inc | Senior VP - CMO | Sell | 64,310 | $4.72 | $303,543.20 | -72.9% | - | - |